SCHEMBL27747166

SCHEMBL27747166

NN(C(=O)O)c1ccc(C(F)(F)F)cn1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 1/20 0.51
TRPM8 Q7Z2W7 1/20 0.46
L3MBTL1 Q9Y468 1/20 0.43
RAB9A P51151 4/20 0.42
NPC1 O15118 2/20 0.42
PTGS1 P23219 1/20 0.42
KDM4E B2RXH2 2/20 0.40
ABL1 P00519 1/20 0.40
LMNA P02545 1/20 0.40
PTGIR P43119 1/20 0.39
POLB P06746 1/20 0.38
ALDH1A1 P00352 1/20 0.38
LIPE Q05469 2/20 0.38
HTT P42858 1/20 0.37
CDK5 Q00535 1/20 0.37
CDK5R1 Q15078 1/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
GAA P10253 1/20 0.37
MRGPRX4 Q96LA9 1/20 0.37
MAPK1 P28482 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6230454 0.77 KMT2A (0.45) KMT2ATRPM8L3MBTL1LMNAPOLB
SCHEMBL14300714 0.76 PTGIR (0.55) KMT2ATRPM8L3MBTL1RAB9ANPC1
SCHEMBL6180145 0.75 KMT2A (0.54) KMT2ATRPM8L3MBTL1RAB9ANPC1
SCHEMBL2787089 0.75 L3MBTL1 (0.47) KMT2ATRPM8L3MBTL1RAB9ANPC1
SCHEMBL6226157 0.74 RPS6KA3 (0.46) KMT2AL3MBTL1KDM4ELMNAPOLB
SCHEMBL28139404 0.74 ALDH1A1 (0.48) KMT2ARAB9ANPC1KDM4EALDH1A1
SCHEMBL27768259 0.74 L3MBTL1 (0.42) KMT2AL3MBTL1RAB9ANPC1PTGIR
SCHEMBL6225886 0.73 TLR7 (0.44) KMT2AL3MBTL1RAB9ASMN1; SMN2GAA
SCHEMBL1978108 0.73 CES2 (0.47) RAB9ANPC1PTGS1KDM4EALDH1A1
SCHEMBL16343437 0.71 CYP1A2 (0.44) PTGS1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-101466710-B Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis BAYER HEALTHCARE LLC 2013-05-29 CN disclosed
CN-101466710-A Substituted 4-amino-pyrrolotriazine derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis BAYER HEALTHCARE LLC (US) 2009-06-24 CN disclosed